Call for Expression of Interest to Join the Global Sepsis Innovations Platform (GSIP)

The Global Sepsis Alliance (GSA) and Sepsis Stiftung are pleased to announce a call for expressions of interest to join the Global Sepsis Innovations Platform (GSIP), which will launch on January 30, 2025.

Aligned with the 2030 Global Agenda for Sepsis - the first multi-year global strategy for sepsis launched at the German Parliament in September 2024 -  GSIP aims to foster coordinated ongoing discussions and advocacy to address unmet needs in sepsis innovations. This includes research & development (R&D) for novel vaccines and other prevention interventions, diagnostics, antimicrobial and immunomodulatory therapies, precision medicine, care and rehabilitation commodities, and AI-enabled technologies.   

The Sepsis Alliance, which led the Sepsis Innovation Collaborative, will be an associated partner to the GSIP.

A Collaborative Approach to Sepsis Innovation

The GSIP will focus on:

  • Knowledge Exchange. Facilitating collaboration among innovators, researchers, healthcare professionals, sepsis survivors, and patients' families. Engaging sepsis survivors ensures that the platform remains focused on addressing unmet needs in prevention, diagnostics, and therapeutics, as well as innovations for post-sepsis care and rehabilitation.

  • Regulatory Collaboration. Promoting multilateral discussions, consensus-building, and recommendations regarding regulations related to R&D, authorization, and licensing of sepsis innovations. Where appropriate, GSIP will submit recommendations and position statements to national and regional regulatory authorities.

  • Advocacy Coordination. Coordinating efforts with national governments, philanthropic foundations, the private sector, the manufacturing industry, public-private partnerships, and research institutions, with active engagement of sepsis survivors and families with lived experiences. Coherent advocacy aims to increase investment in sepsis research and innovations and to prioritize sepsis as a leading cause of death for children, women, and men worldwide.

  • Operational Research Coordination. Supporting discussions, planning, and implementation of operational research to define the accessibility and affordability of basic sepsis-related equipment and supplies, with particular attention to low- and middle-income countries (LMICs), which bear the highest burden of sepsis.

  • Defining the Sepsis R&D Agenda. Facilitating discussions to identify the sepsis R&D priorities, especially for LMICs, including unmet needs in sepsis data (both quantitative and qualitative), traditional and novel vaccines, early detection and treatment strategies, and AI solutions for sepsis diagnostics and management.

For further information, please refer to the Terms of Reference for the Global Sepsis Innovations Platform.

A Call for Participation: Join the GSIP

Organizations from the public, private, civil society, and academic sectors interested in joining the GSIP's work are invited to contact the Berlin head office of the Global Sepsis Alliance via the form below by COB January 10, 2025.

We look forward to expanding opportunities and partnerships to advance sepsis science and R&D for novel solutions that can save millions of lives.

Marvin Zick